50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

Six more U.S. states find Omicron cases, Delta still top U.S. coronavirus threat

Published 12/03/2021, 11:55 AM
Updated 12/03/2021, 08:01 PM
© Reuters. FILE PHOTO: Syringes with needles are seen in front of a displayed stock graph and words "Omicron SARS-CoV-2" in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration
PFE
-
TWTR
-

WASHINGTON (Reuters) - Six more U.S. states confirmed infections of the Omicron variant of COVID-19 on Friday but the Delta strain likely remains a greater threat as winter sets in and Americans gather for the holidays, experts said.

New Jersey, Maryland, Missouri, Nebraska, Pennsylvania and Utah each reported their first cases of the Omicron variant on Friday. Missouri was awaiting CDC confirmation of a case involving a St. Louis resident who had recently traveled within the United States.

Scientists are still investigating the impact of the highly contagious Omicron variant, which was first detected in South Africa. Early evidence has suggested it may cause milder illness than its predecessors, including Delta.

The outbreak of Omicron has made worldwide headlines and prompted political leaders to impose new COVID-19 restrictions. But the predominant U.S. strain remains Delta, Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention (CDC), told a briefing at the White House.

The Utah case was discovered through ongoing genetic sequencing of positive COVID-19 samples at the state laboratory, the state's health department said on Twitter (NYSE:TWTR).

Nebraska had six confirmed cases, the state's health department said. Only one of the six people was vaccinated and none have needed to be hospitalized with COVID-19, the department added.

Maryland Governor Larry Hogan announced the first three cases of the Omicron variant in his state, adding that none of the three individuals were hospitalized. And in Pennsylvania, a Philadelphia man in his 30s tested positive for Omicron, city health officials said.

New Jersey Governor Phil Murphy said the state's first Omicron case had been found in a fully-vaccinated woman who had recently traveled to Georgia.

A surge in infections could further strain U.S. hospitals already grappling with high case loads and fatigued staff, Dr. Ashish Jha, dean of Brown University's School of Public Health, told MSNBC.

"I'm very worried about our healthcare system over the next few weeks and few months. I don't know how much more it can handle," he said, urging reinforcements from the National Guard and other contingency plans to bolster doctors and nurses.

Former FDA Commissioner Dr. Scott Gottlieb said states with higher vaccination rates would likely be better protected against Omicron, saying unvaccinated people who survived Delta could find their immunity is not protective against the new variant.

"The risk for the future is that states that are relying on a lot of Delta infections to provide immunity to their populations... they could be more susceptible to this new variant," Gottlieb, now a member of vaccine maker Pfizer (NYSE:PFE)'s board, told CNBC.

© Reuters. People take coronavirus disease (COVID-19) tests at a pop-up sidewalk testing site in New York, U.S., December 1, 2021.  REUTERS/Brendan McDermid

Omicron has been detected in about 40 countries, including the United States, where it has also been found in California, Colorado, Hawaii, Minnesota, and New York.

The CDC said it was investigating possible cases of the Omicron variant in other U.S. states.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.